UK
https://coronavirus.data.gov.uk
https://covid.joinzoe.com/data#levels-over-time
Cases, + 2,357 + 2,474 = 4,439,691
Deaths, + 4 + 20 = 127,629
Deaths, + 290 (7 days) = 151,533
Vaccinations
https://coronavirus.data.gov.uk/details/vaccinations
First dose, + 115,053 = 35,587,348 (67.6%)
Second dose, + 231,835 = 18,088,385 (34.3%)
France
https://www.aljazeera.com/news/2021/5/10/france-records-20-cases-of-indian-covid-19-variant
India variant, 20 cases, 5 clusters
Olivier Veran, Health Minister
Reopen bars and restaurants for outdoor service on May 19
Vaccinations
One dose, 17.8 million (26.6%)
Second dose, 7.8 million
ITU cases
Saturday, 5,005
Sunday, 4,971
First drop below, 5,000 since March 29
US
https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use
U.S. Food and Drug Administration
Expanded emergency use authorization
Pfizer-BioNTech COVID-19 Vaccine
12 to 15 years of age
Janet Woodcock, (FDA)
allows for a younger population to be protected
bringing us closer to returning to a sense of normalcy
and to ending the pandemic
March 1, 2020 through April 30, 2021
1.5 million COVID-19 cases in individuals 11 to 17 years
Two doses, three weeks apart
Potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks
Scientific Brief: SARS-CoV-2 Transmission (7th May)
https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/sars-cov-2-transmission.html
https://www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted
SARS-CoV-2 is transmitted by exposure to infectious respiratory fluids
People release respiratory fluids
Infection depends on concentration of viral particles
Three principal ways:
Inhalation
Mucous membranes depositions
Touching mucous membranes
Factors in inoculum
Airstream
Thermal layering and
Initial jetting of exhalations
Enclosed spaces
Increased exhalation
Prolonged exposure
Progressive loss of viral viability and infectiousness
Temperature
Humidity
Ultraviolet radiation
Infection still possible
More than 6 feet away
Passing through a space an infectious person has left
Prevention of transmission
Physical distancing
Well-fitting masks
Adequate ventilation
Avoidance of crowded indoor spaces
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00869-2/fulltext
History
CDC, masks, 19th April 2020
https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/cloth-face-cover-guidance.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fprevent-getting-sick%2Fcloth-face-cover.html
WHO, masks, 5th June 2020
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/when-and-how-to-use-masks
https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—5-june-2020
Vaccine factors
https://www.theguardian.com/world/live/2021/may/11/coronavirus-live-news-india-variant-of-concern-globally-says-who-pfizer-vaccine-approved-for-us-12-15-year-olds
AstraZeneca, 20 manufacturing partners around the world
With which it has shared the Covid-19 vaccine technology
India’s Serum Institute, has supplied 300m doses so far to 165 countries
90% of India’s vaccines so far
Providing 98% of the supply to Covax
Pledged not-for-profit basis for the duration
AstraZeneca lost money first three months of the year
Pfizer and Moderna are on course to make $45bn (£32bn) collectively from their coronavirus vaccines this year
Source